BioSpace News Archive

Feb. 20, 2020 13:00 UTC Study reports on the first human cellular and metabolomics-based test for the evaluation of drugs for cardiotoxic effects MADISON, Wis.--( BUSINESS WIRE )-- Stemina Biomarker Discovery, Inc., today announced study results showing the high performance of the company’s Cardio quick Predict test in identifying cardiotoxic effects for a large number of well-characterized drugs. These results suggest the drug screening test could provide drug developers

HeartVista, a pioneer in AI-assisted MRI solutions, announced the formation of its Medical and Scientific Advisory Board, including notable thought leaders from Stanford University and the University of Wisconsin.

Obalon Therapeutics, Inc. (NASDAQ: OBLN), a vertically integrated weight loss solutions company commercializing the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity, announces that it has opened its second Company-managed retail treatment center.

ORLANDO, Fla., Feb. 20, 2020 (GLOBE NEWSWIRE) -- Earlier this week, the medical diagnostic and healthcare tech company opened its fourth quarter earnings book covering the three-month period ending December 31, 2019. Here’s what the company revealed in its latest SEC Form 10-Q (which can be found on the company’s investor page ): Biotricity’s net revenue in Q4 showed a year-over-year increase of 224.63%. Gross revenues earned in Q4 alone is equal to 96% of the gross revenues that had

Partnership brings together Vifor Pharma’s world-class iron deficiency portfolio with Fresenius Kabi’s market-leading patient access in China

In 2019, with the continuous advancement of “three medical integration”, Chengdu Medical City’s three medical innovation center, as “Western China Biomedical Innovation Center”, submitted a satisfactory answer sheet

Galderma today announced that The New England Journal of Medicine (NEJM) has published full results from the Phase 2 study of its investigational therapy nemolizumab in adult patients suffering from moderate-to-severe prurigo nodularis (PN).

Stock market gains and dealmaking activity in Q4 clinched the biopharma sector’s strong performance in 2019 – a stark reversal of the declines seen in the final months of 2018.

On February 4th, Shanghai Public Health Clinical Center, one of the authoritative institutions in the field of infectious diseases in China and the core unit for the treatment of COVID-19 in Shanghai, published the article “AI Aids the Scientific Prevention and Control, Intelligent Evaluation System of Chest CT for COVID-19 Launched in Shanghai Public Health Clinical Center” on its official WeChat platform.

Calidi Biotherapeutics, Inc. (“Calidi”), a clinical‐stage biotechnology company at the forefront of oncolytic virus-based immunotherapies for cancer, today announced the appointment of seasoned biotech executive, Heehyoung Lee, Managing Partner at LumeBio, to its board of directors